ArticleMedicine2026
Causal associations of white blood cell subtypes with age-related hearing loss: A Mendelian randomization study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While elevated white blood cell (WBC) counts are associated with auditory decline, the causal nature of this relationship remains elusive due to potential residual confounding. We utilized 2-sample Mendelian randomization (MR) to assess potential causal relationships between 5 genetically predicted WBC subtypes and the risk of age-related (ARHL) and sensorineural hearing loss. Two-sample MR analyses were conducted using summary statistics from large-scale genome-wide association studies. Causal estimates were assessed via inverse variance weighted, weighted median, weighted mode, and MR-Egger regression methods. Robustness was verified through extensive sensitivity analyses, including Cochran's Q tests, Mendelian Randomization Pleiotropy RESidual Sum and Outlier (MR-PRESSO), Radial MR, and leave-one-out tests, to detect heterogeneity and horizontal pleiotropy. Genetically predicted higher neutrophil counts were significantly associated with a reduced risk of ARHL (odds ratio [OR] = 0.9765, 95% confidence intervals [CI] = 0.9646-0.9886, P = .0002, false discovery rate [FDR] = 0.0015). Nominally significant protective associations were also observed for higher eosinophil (OR = 0.9883, 95% CI = 0.9777-0.9991, P = .0344, FDR = 0.1148) and lymphocyte counts (OR = 0.9858; 95% CI = 0.9745-0.9972, P = .0148, FDR = 0.0739). No significant heterogeneity or pleiotropy was detected in the final analyses for these associations. No causal associations were found between any WBC counts and sensorineural hearing loss. MR Steiger tests confirmed the consistency in causal directions. This MR study provides genetic evidence for a causal protective association between higher neutrophil counts and a reduced risk of ARHL. The potential roles of eosinophils and lymphocytes in ARHL warrant further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.